Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2025-12-31): -27.63%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-25.06%
RETURN ON EQUITY (ROE) AVG 3Y
-158.95%
RETURN ON EQUITY (ROE) AVG 5Y
-98.42%
RETURN ON EQUITY (ROE) AVG 10Y
-60.68%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
VivoSim Labs, Inc.
Market Cap
$518606.00
Return on Equity (ROE)
N/A
TTM Avg
-25.06%
3Y Avg
-158.95%
5Y Avg
-98.42%
Market Cap
$545796.00
Return on Equity (ROE)
-66.26%
TTM Avg
77.79%
3Y Avg
-17.48%
5Y Avg
-22.53%
Market Cap
$481786.00
Return on Equity (ROE)
-68.17%
TTM Avg
-111.11%
3Y Avg
-104.52%
5Y Avg
-88.82%
Market Cap
$403887.00
Return on Equity (ROE)
-5.89%
TTM Avg
-13.04%
3Y Avg
-24.95%
5Y Avg
-31.50%
Market Cap
$378849.00
Return on Equity (ROE)
-66.30%
TTM Avg
-86.35%
3Y Avg
-89.49%
5Y Avg
-12.24%
Market Cap
$667469.00
Return on Equity (ROE)
N/A
TTM Avg
-21.14%
3Y Avg
-26.23%
5Y Avg
-26.18%
Market Cap
$716854.00
Return on Equity (ROE)
6.58%
TTM Avg
129.48%
3Y Avg
106.12%
5Y Avg
-3462.32%
Market Cap
$250443.00
Return on Equity (ROE)
-287.31%
TTM Avg
-182.19%
3Y Avg
-117.96%
5Y Avg
-131.39%
Market Cap
$824550.00
Return on Equity (ROE)
-334.41%
TTM Avg
-290.71%
3Y Avg
-280.75%
5Y Avg
-198.19%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| VivoSim Labs, Inc. (VIVS) | $518606.00 | N/A | -25.06% | -158.95% | -98.42% |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | -66.26% | 77.79% | -17.48% | -22.53% |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | -68.17% | -111.11% | -104.52% | -88.82% |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | -5.89% | -13.04% | -24.95% | -31.50% |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | -66.30% | -86.35% | -89.49% | -12.24% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | N/A | -21.14% | -26.23% | -26.18% |
| CDT Equity Inc. (CDT)vs › | $716854.00 | 6.58% | 129.48% | 106.12% | -3462.32% |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | -287.31% | -182.19% | -117.96% | -131.39% |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | -334.41% | -290.71% | -280.75% | -198.19% |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | N/A | 15.66% | -28.27% | -26.31% |
ROE
N/A
ROA
-320.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -27.63% |
| 2025-09-30 | -28.07% |
| 2025-06-30 | -20.83% |
| 2025-03-31 | -23.71% |
| 2024-09-30 | -340.82% |
| 2024-06-30 | -209.95% |
| 2024-03-31 | -407.41% |
| 2023-12-31 | -308.72% |
| 2023-09-30 | -221.68% |
| 2023-06-30 | -153.46% |
| 2023-03-31 | -112.59% |
| 2022-12-31 | -52.54% |
| 2022-09-30 | -47.78% |
| 2022-06-30 | -43.87% |
| 2022-03-31 | -37.90% |
| 2021-12-31 | -38.77% |
| 2021-09-30 | -32.58% |
| 2021-06-30 | -44.44% |
| 2021-03-31 | -42.93% |
| 2020-12-31 | -81.69% |
| 2020-09-30 | -89.12% |
| 2020-06-30 | -61.15% |
| 2020-03-31 | -70.26% |
| 2019-12-31 | -79.33% |
| 2019-09-30 | -83.67% |
| 2019-06-30 | -70.68% |
| 2019-03-31 | -73.38% |
| 2018-12-31 | -75.97% |
| 2018-09-30 | -73.30% |
| 2018-06-30 | -77.66% |
| 2018-03-31 | -78.06% |
| 2017-12-31 | -78.21% |
| 2017-09-30 | -76.46% |
| 2017-06-30 | -69.47% |
| 2017-03-31 | -61.65% |
| 2016-12-31 | -51.00% |
| 2016-09-30 | -70.56% |
| 2016-06-30 | -70.84% |
| 2016-03-31 | -62.04% |
| 2015-12-31 | -55.04% |
| 2015-09-30 | -45.36% |
| 2015-06-30 | -37.67% |
| 2015-03-31 | -61.78% |
| 2014-12-31 | -59.54% |
| 2014-09-30 | -50.50% |
| 2014-06-30 | -65.06% |
| 2014-03-31 | -53.53% |
| 2013-12-31 | -72.86% |
| 2013-09-30 | -76.71% |
| 2013-06-30 | 130.60% |
| 2013-03-31 | -251.89% |
